SBIR/STTR proposals may be rejected over foreign risk without explanation, leaving companies unable to understand, mitigate, or correct underlying concerns.


SBIR/STTR proposals may be rejected over foreign risk without explanation, leaving companies unable to understand, mitigate, or correct underlying concerns.

NIH clarifies the difference between Highlighted Topics and Funding Opportunities. Misunderstanding the distinction can undermine proposal success.

NIH introduced emergency peer-review modifications that affect evaluation, timelines, and committee operations. Here is what applicants need to know.